RNAi Targets Fungal Genes

This is a news story, published by Phys Org, that relates primarily to Würzburg news.

disease research news

For more disease research news, you can click here:

more disease research news

Phys Org news

For more news from Phys Org, you can click here:

more news from Phys Org

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about

new antifungal therapies

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest antifungal medication news, antifungals news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Enhanced antifungal activity

Phys Org

•

Health

RNA interference and nanomedicine join forces to fight dangerous fungal infections

Summary

Nutrition label

87% Informative

Research team from Würzburg has succeeded for the first time in packaging small interfering RNAs (siRNAs) with Amphotericin B in anionic liposomes to specifically target the dangerous mold fungus Aspergillus fumigatus.

RNA interference acts like a "gene switch," selectively silencing specific genes.

This RNAi approach shuts down vital fungal genes, thereby inhibiting pathogen growth.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

possibly offensive